Prognostic Value of Hemoglobin Concentration on Renal Outcomes with Diabetic Kidney Disease: A Retrospective Cohort Study
- PMID: 38529168
- PMCID: PMC10962468
- DOI: 10.2147/DMSO.S452280
Prognostic Value of Hemoglobin Concentration on Renal Outcomes with Diabetic Kidney Disease: A Retrospective Cohort Study
Abstract
Objective: Diabetic kidney disease (DKD) patients with anemia face an elevated risk of glomerular filtration rate decline. However, the association between hemoglobin and estimated Glomerular Filtration Rate (eGFR) progression remains to be elucidated.
Methods: A retrospective cohort of 815 subjects with DKD was followed from January 2010 to January 2023. A Cox proportional hazard regression model was utilized to explore the predictive role of hemoglobin in renal outcomes. Renal outcomes were defined as a composite endpoint, including a 50% decline in eGFR from baseline or progression to End-Stage Renal Disease (ESRD). To unveil any nonlinear relationship between hemoglobin and renal outcomes, Cox proportional hazard regression with cubic spline functions and smooth curve fitting was conducted. Additionally, subgroup analyses were performed to identify specific patient populations that might derive greater benefits from higher hemoglobin.
Results: Among the 815 DKD subjects, the mean age was 56.482 ± 9.924 years old, and 533 (65.4%) were male. The mean hemoglobin was 121.521±22.960 g/L. The median follow-up time was 21.103±18.335 months. A total of 182 (22.33%) individuals reached the renal composite endpoint during the study period. After adjusting for covariates, hemoglobin was found to exert a negative impact on the renal composite endpoint in patients with DKD (HR 0.975, 95% CI [0.966, 0.984]). A nonlinear relationship between hemoglobin and the renal composite endpoint was identified with an inflection point at 109 g/L. Subgroup analysis unveiled a more pronounced association between hemoglobin and renal prognosis in males.
Conclusion: Hemoglobin emerges as a predictive indicator for the renal prognosis of diabetic kidney disease in China. This study reveals a negative and non-linear relationship between hemoglobin levels and the renal composite endpoint. A substantial association is noted when hemoglobin surpasses 109 g/L in relation to the renal composite endpoint.
Keywords: Cox proportional-hazards regression; ESRD; diabetic kidney disease; eGFR decline; hemoglobin; non-linear.
© 2024 Chen et al.
Conflict of interest statement
The authors declare that they have no competing interests in this work.
Figures






Similar articles
-
Association between hemoglobin and chronic kidney disease progression: a secondary analysis of a prospective cohort study in Japanese patients.BMC Nephrol. 2022 Aug 23;23(1):295. doi: 10.1186/s12882-022-02920-6. BMC Nephrol. 2022. PMID: 35999502 Free PMC article.
-
Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.Nephrol Dial Transplant. 2022 Feb 25;37(3):489-497. doi: 10.1093/ndt/gfab185. Nephrol Dial Transplant. 2022. PMID: 34028524
-
Urinary uromodulin independently predicts end-stage renal disease and rapid kidney function decline in a cohort of chronic kidney disease patients.Medicine (Baltimore). 2019 May;98(21):e15808. doi: 10.1097/MD.0000000000015808. Medicine (Baltimore). 2019. PMID: 31124979 Free PMC article.
-
Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.Ren Fail. 2022 Dec;44(1):1309-1318. doi: 10.1080/0886022X.2022.2106872. Ren Fail. 2022. PMID: 35938702 Free PMC article.
-
Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease.Int Immunopharmacol. 2021 Apr;93:107413. doi: 10.1016/j.intimp.2021.107413. Epub 2021 Jan 29. Int Immunopharmacol. 2021. PMID: 33524800
Cited by
-
A Machine Learning Model for Predicting Diabetic Nephropathy Based on TG/Cys-C Ratio and Five Clinical Indicators.Diabetes Metab Syndr Obes. 2025 Mar 31;18:955-967. doi: 10.2147/DMSO.S502649. eCollection 2025. Diabetes Metab Syndr Obes. 2025. PMID: 40191828 Free PMC article.
-
Prognostic Value of Hemoglobin Concentration on Renal Outcomes with Diabetic Kidney Disease: A Retrospective Cohort Study [Letter].Diabetes Metab Syndr Obes. 2024 Apr 12;17:1699-1700. doi: 10.2147/DMSO.S471641. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38629026 Free PMC article. No abstract available.
-
Correlation analysis between hemoglobin and type 2 diabetic nephropathy: a two-center retrospective study.Acta Diabetol. 2025 Jul;62(7):1149-1156. doi: 10.1007/s00592-025-02529-9. Epub 2025 Jun 5. Acta Diabetol. 2025. PMID: 40471290 Free PMC article.
References
-
- Wysham CH, Gauthier-Loiselle M, Bailey RA, et al. Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study. Curr Med Res Opin. 2020;36(2):219–227. doi:10.1080/03007995.2019.1682981 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous